This financing round was led by Ganjiang Kai Investment, a state-owned investment platform in Ganjiang, Jiangxi Province, and was followed by Central Enterprises Poor Regions Industry Investment Fund Co., and Neovision Capital.
Dakang, founded in 2012, now has China's most independent dialysis centers. The company operates nearly 60 independent dialysis centers, in 15 provinces, including Jiangxi, Shandong, Yunnan, and Guizhou. It also has a talented crew of roughly 800 professional dialysis doctors, nurses, and technical experts.
Before China encouraged social capital to participate in dialysis service, Dakang undertook the former Ministry of Health's pilot work to conduct independent dialysis. After nearly ten years of development, it has completed its early-stage commercialization as an independent dialysis provider and achieved profitability for most of its facilities.
In the future, Dakang Medical Investment Co., Ltd. intends to open approximately 1,000 independent blood purification centers nationwide. Simultaneously, by leveraging the nationwide network of kidney hospitals, the company can strengthen the case management for the entire course of diseases and build a comprehensive industry chain for nephropathy treatment.